NCT03042130

Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Tel-Aviv Sourasky Medical Center · Other Government
• Sex: All
• Age: 18 Years – 120 Years
• Healthy volunteers: Not accepted

Summary

Patients with congestive heart failure, grade 3-4, in addition to the standard care, will be randomized 1:1. The study group will receive 2 doses of IV iron (Iron carboxymaltose). The control group will receive standard of care alone. The study will test for the effects of the additional IV iron on the symptoms, clinical picture and quality of life of the treated patients.

Detailed description

Patients with congestive heart failure, grade 3-4, in addition to the standard care, will be randomized 1:1. The study group will receive 2 doses of IV iron (Iron carboxymaltose). The control group will receive standard of care alone. The study will test for the effects of the additional IV iron on the symptoms, clinical picture and quality of life of the treated patients. The parameters that will be measured will include clinical, lab, echo, and quality of life questionnaires.

Conditions

• Heart Failure

Interventions

Type	Name	Description
OTHER	Standard of care	standard of care
DRUG	Iron Carboxymaltose	Two IV doses

Timeline

• Start date: 2016-12-14
• Primary completion: 2018-02-06
• Completion: 2018-02-06
• First posted: 2017-02-03
• Last updated: 2018-02-28

Locations

1 site across 1 country: Israel